Advertisement

The Influence of Terpenes and Analogues on Parameters of Atherosclerosis

  • D. A. White
  • G. D. Bell
  • F. Cacciaguerra
  • B. Middleton
Conference paper
Part of the Proceedings in Life Sciences book series (LIFE SCIENCES)

Abstract

Rowachol, a proprietary mixture of the six monoterpenes menthol, menthone, borneol, cineole, camphene and pinene in olive oil, reduced the lithogenicity of bile (Doran et al. 1979) and caused dissolution of cholesterol gallstones in man (Bell and Doran 1979). Daily administration of the drug (6–9 capsules) to 16 patients for periods of 2–28 weeks gave a progressive increase in serum HDL-cholesterol concentration with no accompanying change in the concentrations of serum total cholesterol or triglyceride (Bell et al. 1980) (Fig. 1). Similar effects in humans have been shown recently by Leiss and von Bergmann (1985) who administered Rowachol (200 mg t.i.d) to young healthy volunteers and measured a significant increase in the ratio of HDL-cholesterol to total cholesterol in serum.

Keywords

Cholesteryl Ester Cholesterol Gallstone ACAT Activity Serum High Density Lipoprotein Cholesterol Hepatic Cholesterol Synthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bell GD, Doran J (1979) Gallstone dissolution in man using an essential oil preparation. Brit Med J 1:24PubMedCrossRefGoogle Scholar
  2. Bell GD, Bradshaw JP, Burgess A, Ellis W, Hatton J, Middleton A, Middleton B, Orchard T, White DA (1980) Elevation of serum high density lipoprotein cholesterol by Rowachol, a proprietary mixture of six pure monoterpenes. Atherosclerosis 36:47–54PubMedCrossRefGoogle Scholar
  3. Bell GD, Clegg RJ, Ellis WR, Middleton B, White DA (1984) The effects of 3,5–5-trimethylcyclohexanol on hepatic cholesterol synthesis, bile-flow and biliary lipid secretion in the rat. Br J Pharmacol 81:183–187PubMedGoogle Scholar
  4. Clegg RJ, Middleton B, Bell GD, White DA (1980) Inhibition of hepatic cholesterol synthesis and S-3-hydroxy-3-methylglutaryl-CoA reductase by mono-and bicyclic monoterpenes administered in vivo. Biochem Pharmacol 29:2125–2127PubMedCrossRefGoogle Scholar
  5. Clegg RJ, Middleton B, Bell GD, White DA (1982) The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem 257:2294–2299PubMedGoogle Scholar
  6. Doran J, Keighley MRB, Bell GD (1979) Rowachol — possible treatment for cholesterol gallstones. Gut 20:312–317PubMedCrossRefGoogle Scholar
  7. Leiss O, Bergmann K von (1985) Effect of Rowachol on biliary lipid secretion and serum lipids in normal volunteers. Gut 26:32–37PubMedCrossRefGoogle Scholar
  8. Middleton A, White DA, Bell GD, Middleton B (1983) In vivo inhibition of hepatic lipogenesis in the rat by cyclandelate (3,3′,5-trimethylcyclohexanylmandelate). Biochem Pharmacol 32:3079–3083PubMedCrossRefGoogle Scholar
  9. Middleton B, Middleton A, Miciak A, White DA, Bell GD (1983) The inhibition of hepatic S-3-hydroxy-3-methylglutaryl-CoA reductase by 3,3,5-trimethylcyclohexanol and its mandelicacid ester, cyclandelate. Biochem Pharmacol 32:649–651PubMedCrossRefGoogle Scholar
  10. Middleton B, Middleton A, White DA, Bell GD (1984) Cyclandelate decreases pre-established atherosclerosis in the rabbit. Atherosclerosis 51:171–178PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • D. A. White
    • 1
  • G. D. Bell
    • 2
  • F. Cacciaguerra
    • 1
  • B. Middleton
    • 1
  1. 1.Department of Biochemistry, Queen’s Medical CentreUniversity of Nottingham Medical SchoolNottinghamEngland
  2. 2.Department of MedicineThe Ipswich HospitalIpswich, SuffolkEngland

Personalised recommendations